Visual behavioral deficits correlate with retinal thinning but not cumulative intraocular pressure elevation after intracameral injection of an optically clear hydrogel

Abstract

Purpose : Development and pre-clinical testing of glaucoma neurotherapeutics have been obfuscated by limited experimental models that provide chronic elevation of intraocular pressure (IOP) while preserving optical media clarity for structural and functional assessments over time. In this study, we developed an in vivo model system involving the use of non-invasive tonometry, optical coherence tomography (OCT) and optokinetics to characterize retinal integrity and visual behavior in a novel hydrogel-induced chronic IOP elevation model.

Methods : Six adult C57BL/6J mice underwent unilateral intracameral injection of an optically clear, chemically cross-linked hydrogel composed of hyaluronic acid functionalized with vinyl sulfone and thiol groups. IOP was measured with a rebound tonometer at baseline and 1, 3, 7, 10 and 14 days after hydrogel injection. The optic nerve head (ONH) region was scanned for each eye using OCT at baseline and 2 weeks after injection, and total retinal thickness (TRT) was measured within a 0.26-0.36 mm radius ring centered on the ONH using custom-written software (Fig 1). Visual acuity (VA) was measured for each eye using an optokinetic virtual-reality system at baseline and 2 weeks after injection. Data are presented as mean±SEM.

Results : Intracameral hydrogel injection resulted in mild-to-moderate IOP elevation throughout the 2-week experimental period (Fig 2a). TRT in the hydrogel-injected eye was 10.06±3.61% thinner at 2 weeks post-injection compared to baseline (p<0.01) (Fig 2b). IOP elevation also led to a decline in VA by 58.12±7.22% at 2 weeks post-injection compared to baseline (p<0.001) (Fig 2c). Interestingly, among the hydrogel-injected eyes, cumulative IOP measured from 0 to 14 days post-injection did not correlate with TRT or VA (p>0.05) (Fig 2d-e), whereas TRT was positively associated with VA at 2 weeks post-injection (r=0.824, p<0.05) (Fig 2f). No significant change in IOP, TRT or VA was found in the non-injected eye.

Conclusions : An in vivo glaucoma model system was developed that showed a positive correlation between retinal thinning and visual behavioral deficits after chronic IOP elevation. The weak association between cumulative IOP and TRT or VA suggests additional factors apart from IOP level in contributing to glaucomatous damage after chronic IOP elevation.

This is a 2020 ARVO Annual Meeting abstract.